Aarti Pharmalabs Limited (AARTIPHARM) Price & Analysis

Compare

1 Followers

AARTIPHARM Stock Chart & Stats

₹842.40

₹9.55(1.45%)

At close: Jan 09 4:00 PM EST

₹842.40

₹9.55(1.45%)

Day’s Range― - ―

52-Week Range₹557.20 - ₹971.50

Previous CloseN/A

Volume141.60K

Average Volume (3M)18.67K

Market Cap

₹62.76B

Enterprise Value₹68.66B

Total Cash (Recent Filing)₹562.06M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)29.2

Beta0.72

Next Earnings

May 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.67%

Share Statistics

EPS (TTM)5.29

Shares Outstanding90,647,290

10 Day Avg. Volume12,195

30 Day Avg. Volume18,670

Financial Highlights & Ratios

PEG Ratio0.98

Price to Book (P/B)3.43

Price to Sales (P/S)3.23

P/FCF Ratio-96.96

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹965.00

Price Target Upside14.55% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthA low debt-to-equity ratio and high equity share signal conservative leverage and a solid capital base, reducing refinancing risk. Improved ROE indicates efficient capital use; this financial flexibility supports long-term capex, R&D or contract wins without stressing solvency.

Margin ImprovementSustained high gross and healthy EBITDA margins reflect cost control and pricing power in APIs/intermediates. Strong margin structure provides durable buffer against raw material swings and supports reinvestment, making profits more resilient over the medium term.

Recent Revenue ExpansionDouble-digit top-line growth year-over-year indicates expanding commercial traction and stronger demand for API products. For a B2B manufacturer, this suggests improving capacity utilization and customer wins, which can translate to durable revenue momentum if sustained.

Bears Say

Negative Free Cash FlowNegative free cash flow driven by high capex means accounting profits aren't converting to available cash. Persisting FCF deficits can force external financing, constrain dividends or limit strategic investments, raising medium-term liquidity and execution risk.

Reported Revenue-growth InconsistencyConflicting indicators on revenue growth suggest volatility or timing differences in reported metrics. Structural uncertainty in top-line trends complicates forecasting and may reflect uneven order flows or customer concentration, weakening predictability of future cash flows.

Earnings Per Share ContractionNegative EPS growth indicates per-share profitability has declined, which can stem from margin pressure, higher costs, or dilution. Over the medium term, falling EPS reduces retained earnings and the company’s ability to self-fund growth or return capital to shareholders.

Aarti Pharmalabs Limited News

Aarti Pharmalabs Posts Q3 FY26 Earnings Call Recording Online

Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ) has issued an update. Aarti Pharmalabs Limited has announced that the audio...

15d ago

Aarti Pharmalabs Schedules Q3 FY26 Earnings Call for 10 February

Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ) just unveiled an announcement. Aarti Pharmalabs Limited has scheduled an earnings conference...

23d ago

Aarti Pharmalabs Reports Stable Financial Performance for H1 2025

Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ) has provided an announcement. Aarti Pharmalabs Limited announced its unaudited financial results...

4M ago

Aarti Pharmalabs Submits SEBI Compliance Certificate for Q3 2025

Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ) just unveiled an update. Aarti Pharmalabs Limited, a company involved in the...

5M ago

Aarti Pharmalabs Schedules Analyst and Investor Meeting

The latest announcement is out from Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ). Aarti Pharmalabs Limited, a company involved...

5M ago

Aarti Pharmalabs Awaits Clarification on Financial Discrepancies

Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ) has shared an update. Aarti Pharmalabs Limited has been asked by the...

6M ago

Aarti Pharmalabs Expands with New Manufacturing Facility in Gujarat

Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ) has provided an update. Aarti Pharmalabs Limited has inaugurated the first phase...

6M ago

Aarti Pharmalabs Updates Registrar Contact Details

The latest update is out from Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ). Aarti Pharmalabs Limited has announced a...

10M ago

Aarti Pharmalabs Forms Joint Venture with Ganesh Polychem

The latest announcement is out from Aarti Pharmalabs Limited ( ($IN:AARTIPHARM) ). Aarti Pharmalabs Limited has announced an...

11M ago

Aarti Pharmalabs Limited (AARTIPHARM) Discloses Q1 Dividend: What Shareholders Should Know

Aarti Pharmalabs Limited (NSE: AARTIPHARM) has declared, under its dividend policy, a yearly cash dividend in the amount...

1y ago

AARTIPHARM FAQ

What was Aarti Pharmalabs Limited’s price range in the past 12 months?

Aarti Pharmalabs Limited lowest stock price was ₹557.20 and its highest was ₹971.50 in the past 12 months.

What is Aarti Pharmalabs Limited’s market cap?

Aarti Pharmalabs Limited’s market cap is ₹62.76B.

When is Aarti Pharmalabs Limited’s upcoming earnings report date?

Aarti Pharmalabs Limited’s upcoming earnings report date is May 11, 2026 which is in 75 days.

How were Aarti Pharmalabs Limited’s earnings last quarter?

Aarti Pharmalabs Limited released its earnings results on Feb 09, 2026. The company reported ₹5.29 earnings per share for the quarter, beating the consensus estimate of N/A by ₹5.29.

Is Aarti Pharmalabs Limited overvalued?

According to Wall Street analysts Aarti Pharmalabs Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Aarti Pharmalabs Limited pay dividends?

Aarti Pharmalabs Limited pays a Semiannually dividend of ₹2.5 which represents an annual dividend yield of 0.67%. See more information on Aarti Pharmalabs Limited dividends here

What is Aarti Pharmalabs Limited’s EPS estimate?

Aarti Pharmalabs Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aarti Pharmalabs Limited have?

Aarti Pharmalabs Limited has 90,647,290 shares outstanding.

What happened to Aarti Pharmalabs Limited’s price movement after its last earnings report?

Aarti Pharmalabs Limited reported an EPS of ₹5.29 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.36%.

Which hedge fund is a major shareholder of Aarti Pharmalabs Limited?

Currently, no hedge funds are holding shares in IN:AARTIPHARM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aarti Pharmalabs Limited

Aarti Pharmalabs Limited manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xanthine derivatives in India. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.

Aarti Pharmalabs Limited (AARTIPHARM) Earnings & Revenues

Historic Earnings Reports

AARTIPHARM Stock 12 Month Forecast

Average Price Target

₹965.00

▲(14.55% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"579":"₹579","966":"₹966","675.75":"₹675.8","772.5":"₹772.5","869.25":"₹869.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":965,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹965.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":965,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹965.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":965,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹965.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[579,675.75,772.5,869.25,966],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,770.114,785.1052307692308,800.0964615384615,815.0876923076924,830.078923076923,845.0701538461539,860.0613846153847,875.0526153846154,890.0438461538462,905.035076923077,920.0263076923077,935.0175384615385,950.0087692307692,{"y":965,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,770.114,785.1052307692308,800.0964615384615,815.0876923076924,830.078923076923,845.0701538461539,860.0613846153847,875.0526153846154,890.0438461538462,905.035076923077,920.0263076923077,935.0175384615385,950.0087692307692,{"y":965,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,770.114,785.1052307692308,800.0964615384615,815.0876923076924,830.078923076923,845.0701538461539,860.0613846153847,875.0526153846154,890.0438461538462,905.035076923077,920.0263076923077,935.0175384615385,950.0087692307692,{"y":965,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":580.151,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":730.518,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":749.029,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":709.967,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":885.469,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":908.209,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":861.485,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":852.628,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":827.842,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":849.097,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":700.712,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":742.274,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":770.114,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >